Dysthyroid optic neuropathy treated with tocilizumab
Dysthyroid optic neuropathy (DON) is the most serious complication associated with Graves’ orbitopathy (GO). The primary treatment approach for DON is high-dose intravenous methylprednisolone infusion and decompression surgery. However, not all patients are suitable candidates for or can tolerate th...
| Published in: | Endocrinology, Diabetes & Metabolism Case Reports |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-02-01
|
| Subjects: | |
| Online Access: | https://edm.bioscientifica.com/view/journals/edm/2025/1/EDM-24-0045.xml |